From: Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience
Characteristics | RT (n = 27) | RChT (n = 35) | |
---|---|---|---|
Age – years | |||
Median | 69.6 | 70.4 | 69.3 |
Range | 65.1–85.6 | 65.8–85.6 | 65.1–78.8 |
Sex – no. (%) | |||
Male | 32 (51.6) | 9 (33.3) | 23 (65.7) |
Female | 30 (48.4) | 18 (66.6) | 12 (34.3) |
ECOG-Score – no. (%) | |||
0 | 9 | 0 | 9 (25.7) |
1 | 28 | 8 (29.6) | 20 (57.1) |
2 | 18 | 13 (48.1) | 5 (14.3) |
3 | 6 | 6 (22.2) | 0 |
Missing | 1 | 0 | 1 (2.9) |
Extent of surgery – no. (%) | |||
Biopsy only | 7 (11.3) | 5 (18.5) | 2 (5.7) |
Subtotal resection | 34 (54.8) | 17 (68.0) | 17 (48.6) |
Gross total resection | 21 (33.9) | 5 (18.5) | 16 (45.7) |
MGMT-promotor | |||
Methylated – no. | 15 | 4 | 11 |
Non-methylated – no. | 22 | 10 | 12 |
Missing – no. | 25 | 13 | 12 |
Time from Surgery to RT (d) | |||
Median | 28.5 | 29 | 28 |
Range | 12–61 | 12–58 | 14–61 |
RT regimen (total/ single; Gy) | |||
42/3 | 12 | 12 | 0 |
40.05/2.67 | 8 | 8 | 0 |
60/2 or 59.4/1.8 | 34 | 3 | 31 |
other | 8 | 4 | 4 |
Salvage Treatment – no. | 23 | 3 | 20 |
Radiotherapy | 14 | 0 | 14 |
Chemotherapy | 15 | 1 | 14 |
Surgery | 14 | 2 | 12 |